How we make money.
The Script Digest earns commissions when readers sign up with brands featured in our reviews. We disclose it here, at the top of every page, and on every outbound link. Full details below.
When a reader clicks a link on our site to a telehealth brand we have an affiliate relationship with, and completes a paid signup, that brand pays a commission to our affiliate network partner, who pays us. The price the reader pays is not increased by our involvement.
These commissions fund our editorial operations — writing reviews, updating them quarterly, paying clinician reviewers, and operating the site. They do not shape our editorial conclusions. See our editorial policy for how we maintain independence.
Current, active commercial relationships (April 2026):
| Brand | Category | Network | Model |
|---|---|---|---|
| Quad by MEDVi | ED (Erectile Dysfunction) | Katalys | CPA — we earn when a reader completes a paid signup |
This list is updated when relationships start or end. If you see a brand reviewed on this site that is not listed here, it means we do not have an active affiliate relationship with them.
Every outbound link to a brand we have an affiliate relationship with is routed through our transparent redirect handler at thescriptdigest.com/go/[brand]. We do not cloak affiliate URLs. The destination brand and the affiliate tracking parameters are visible in the final URL.
Every affiliate link is marked on our pages with language that makes the commercial nature clear. Every review carries the disclosure banner at the top of the page.
- —We do not accept payment for positive coverage.
- —We do not allow brands to approve editorial before publication.
- —We do not remove or modify reviews at a brand's request.
- —We do not operate paid-placement rankings — our reviews are not ranked by commission rate.
- —We do not accept gifts, travel, or other benefits from brands that would create a conflict of interest.
This disclosure is published in compliance with the US Federal Trade Commission's Endorsement Guides (16 CFR Part 255), most recently updated in 2023. Questions or concerns about our disclosure practices can be sent to hello@thescriptdigest.com.